NYSE$ITGR
Integer Holdings Corporation · Q2 2023 earnings
Q2 2023 earnings · · Investor relations
Briefing
Integer delivered strong sales and profit growth, increasing full year sales outlook to 12% growth and adjusted operating income outlook to 19% growth.
Integer Holdings Corporation reported strong second quarter results with increased sales and profit growth. The company is increasing its full year sales outlook to 12% growth and adjusted operating income outlook to 19% growth.
- Integer delivered another strong quarter of sales and profit growth supported by an improving supply chain and labor environment.
- Strong customer demand across product lines.
- Increased full year sales outlook to 12% growth at the midpoint.
- Raised adjusted operating income outlook to 19% growth at midpoint.
Headline financials
Revenue & EPS history
Integer · Revenue · Quarterly
$400M
Revenue by segment
Integer · $266M total across 2 segments · Q1 2023
- Cardio & Vascular$149M—56.0%
- Cardiac Rhythm Management & Neuromodulation$117M—44.0%
Forward guidance
Integer is increasing its full year sales outlook to 12% growth at the midpoint and raising adjusted operating income outlook to 19% growth at midpoint.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 20 quarterly earnings reports · overlaid with Q2 2023
-0.5%
Avg return
Earnings day
+0.4%
Avg return
5 days after
+2.4%
Avg return
30 days after
41%
25 / 61 earnings
Positive
+16.4%
Q3 2016
Best reaction
-33.2%
Q3 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | -0.3% | +2.6% | +6.8% | |
| Q4 2025 | -3.4% | +0.7% | -2.8% | |
| Q3 2025 | -33.2% | -37.7% | -35.8% | |
| Q1 2025 | +0.8% | +5.3% | -1.8% | |
| Q4 2024 | -5.6% | -10.8% | -19.6% | |
| Q3 2024 | -0.6% | +2.8% | +9.2% | |
| Q2 2024 | -6.2% | -2.5% | +1.7% | |
| Q1 2024 | -11.1% | -9.4% | -0.5% | |
| Q4 2023 | -5.4% | -4.5% | +8.3% | |
| Q3 2023 | +13.6% | +16.9% | +29.0% | |
| Q2 2023 | +5.5% | +6.5% | -5.4% | |
| Q1 2023 | +1.3% | +0.3% | -1.2% | |
| Q4 2022 | +6.0% | +2.4% | +1.4% | |
| Q3 2022 | +4.2% | +6.4% | +20.0% | |
| Q2 2022 | -0.5% | -0.3% | -5.2% | |
| Q1 2022 | -5.1% | -1.6% | +1.7% | |
| Q4 2021 | -2.2% | -5.5% | -7.2% | |
| Q3 2021 | -1.6% | -2.1% | -9.0% | |
| Q2 2021 | -0.9% | -3.2% | -0.5% | |
| Q1 2021 | -2.1% | -2.6% | -5.7% | |
| Q4 2020 | +9.6% | +9.3% | +15.5% | |
| Q3 2020 | -4.1% | -4.6% | +19.3% | |
| Q2 2020 | -6.0% | -9.3% | -0.1% | |
| Q1 2020 | +6.3% | +2.3% | +19.0% | |
| Q4 2019 | +4.9% | +1.0% | -45.2% | |
| Q3 2019 | -1.1% | -1.1% | -2.3% | |
| Q2 2019 | -3.7% | -7.8% | -17.3% | |
| Q1 2019 | +10.7% | +11.7% | +3.5% | |
| Q4 2018 | +0.7% | +3.0% | -1.3% | |
| Q3 2018 | +13.1% | +18.0% | +18.9% | |
| Q2 2018 | -0.9% | +0.5% | +11.9% | |
| Q1 2018 | +13.0% | +16.8% | +17.6% | |
| Q4 2017 | +16.0% | +13.9% | +24.6% | |
| Q3 2017 | -2.7% | -4.1% | -2.2% | |
| Q2 2017 | +2.7% | +2.0% | +0.4% | |
| Q1 2017 | +2.5% | +12.3% | +13.9% | |
| Q4 2016 | -0.7% | +2.9% | +7.0% | |
| Q3 2016 | +16.4% | +15.8% | +51.9% | |
| Q2 2016 | -30.4% | -29.7% | -26.5% | |
| Q1 2016 | -10.4% | — | — | |
| Q4 2015 | -14.3% | — | — | |
| Q3 2015 | +6.4% | — | — | |
| Q2 2015 | +4.0% | — | — | |
| Q1 2015 | -3.5% | — | — | |
| Q4 2014 | +1.0% | — | — | |
| Q1 2014 | -4.0% | — | — | |
| Q3 2014 | +6.8% | — | — | |
| Q2 2014 | +2.9% | — | — | |
| Q1 2013 | -5.1% | — | — | |
| Q4 2012 | +0.1% | — | — | |
| Q3 2012 | -0.5% | — | — | |
| Q2 2012 | +1.3% | — | — | |
| Q1 2011 | -1.4% | — | — | |
| Q1 2012 | +0.6% | — | — | |
| Q4 2011 | -2.8% | — | — | |
| Q1 2010 | -2.8% | — | — | |
| Q3 2010 | -3.6% | — | — | |
| Q3 2011 | -3.6% | — | — | |
| Q2 2011 | -0.8% | — | — | |
| Q2 2010 | -0.8% | — | — | |
| Q4 2010 | -0.8% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro